Clinical trials
Phase 1 Bone Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Boston Scientific Corporation | 2 |
| National Cancer Institute (NCI) | 2 |
| Shanghai Yunying Medical Technology | 2 |
| University of Southern California | 2 |
| Alberta Health services | 1 |
| Celgene | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| David Dickens | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Neoplasms | 35 |
| Sarcoma | 18 |
| Osteosarcoma | 9 |
| Breast Neoplasms | 6 |
| Melanoma | 6 |
| Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Lung Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Neuroectodermal Tumors, Primitive, Peripheral | 3 |
Trials
Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.